Litcius/Paper detail

DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome

Coral K. Wille, Rupa Sridharan

2022Stem Cell Reports23 citationsDOIOpen Access PDF

Abstract

Inhibiting the histone 3 lysine 79 (H3K79) methyltransferase, disruptor of telomeric silencing 1-like (DOT1L), increases the efficiency of reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Here, we find that, despite the enrichment of H3K79 methylation on thousands of actively transcribed genes in somatic cells, DOT1L inhibition (DOT1Li) does not immediately cause the shutdown of the somatic transcriptional profile to enable transition to pluripotency. Contrary to the prevalent view, DOT1Li promotes iPSC generation beyond the mesenchymal to epithelial transition and even from already epithelial cell types. DOT1Li is most potent at the midpoint of reprogramming in part by repressing Nfix that persists at late stages of reprogramming. Importantly, regulation of single genes cannot substitute for DOT1Li, demonstrating that H3K79 methylation has pleiotropic effects in maintaining cell identity.

Topics & Concepts

ReprogrammingBiologySomatic cellTranscriptomeInduced pluripotent stem cellCell biologyDNA methylationMethylationGene silencingEpigeneticsHistoneGeneticsEmbryonic stem cellCellGeneGene expressionEpigenetics and DNA MethylationPluripotent Stem Cells ResearchRenal and related cancers
DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome | Litcius